DENNIS MUNGALL, PHARM. D.; ROBERT L. TALBERT, PHARM. D.; CHARLES PHILLIPS, M.D.; DANIEL JAFFE, M.D.; THOMAS M. LUDDEN, PH.D
This content is PDF only. Please click on the PDF icon to access.
To the editor: Sucralfate has recently been introduced for the treatment of duodenal peptic ulcer disease (1). Little information is available on the interaction in humans of sucralfate and other drugs (2). The present case may represent an interaction of warfarin and sucralfate.
A 59-year-old man was admitted to the coronary care unit on 27 July 1982 to rule out myocardial infarction. The patient's medical history included a previous myocardial infarction in 1981 complicated by mural thrombus peptic ulcer disease, and adult onset diabetes. Admission medications included chlorpropamide, 250 mg/d; digoxin, 0.25 mg/d; furosemide, 40 mg/d; potassium chloride, 40 meq/d;
MUNGALL D, TALBERT RL, PHILLIPS C, et al. Sucralfate and Warfarin. Ann Intern Med. 1983;98:557. doi: https://doi.org/10.7326/0003-4819-98-4-557_2
Download citation file:
Published: Ann Intern Med. 1983;98(4):557.
Copyright © 2019 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use